1. Boix, L, Briux, J, Castells, A, Vianney, A, Llovet, JM, Rivera, F & Rodes, J (1996). Circulating mRNA for alpha-fetoprotein in patients with hepatocellular carcinoma. Evidence of tumor dissemination after trans arterial embolization [Abstract]. Hepatology 24: 349A.
2. Bruix, J (1997). Treatment of hepatocellular carcinoma. Hepatology 25: 259–262.
3. Di Stefano, G, Busi, C, Derenzini, M, Trerè, D & Fiume, L (1998). Conjugation of 5-fluoro-2′-deoxyuridine with lactosaminated poly-L-lysine to reduce extrahepatic toxicity in the treatment of hepatocarcinomas. Ital J Gastroenterol Hepatol 30: 173–177.
4. Edmondson, HA & Steiner, PE (1953). Primary carcinoma of the liver: a study on 100 cases among 489 000 necropsies. Cancer 7: 462–503.
5. Fiume, L, Di Stefano, G, Busi, C, Mattioli, A, Bonino, F, Torrani Cerenzia, M, Verme, G, Rapicetta, M, Bertini, M & Gervasi, GB (1997). Liver targeting of antiviral nucleoside analogues through the asialoglycoprotein receptor. J Viral Hepatol 4: 363–370.